SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-021571
Filing Date
2021-06-02
Accepted
2021-06-02 17:12:19
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13455
  Complete submission text file 0000899243-21-021571.txt   15712
Mailing Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan XI L.P. (Reporting) CIK: 0001712417 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 21990125

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan Partners XI LLC (Reporting) CIK: 0001850694 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 21990124